Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study

INTRODUCTION: The metabolic syndrome (MetS) may contribute to the excess cardiovascular burden observed in rheumatoid arthritis (RA). The prevalence and associations of the MetS in RA remain uncertain: systemic inflammation and anti-rheumatic therapy may contribute. Methotrexate (MTX) use has recent...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Toms, Tracey E, Panoulas, Vasileios F, John, Holly, Douglas, Karen MJ, Kitas, George D
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2009
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2745792/
https://ncbi.nlm.nih.gov/pubmed/19607680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar2765
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars